Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Bazylevich, A."'
Autor:
Panja, Akash, Sharma, Vipin, Mitra, Pousali, Bazylevich, Andrii, Drori, Chen, Kayet, Anirban, Tobi, Dror, Patsenker, Leonid, Firer, Michael, Gellerman, Gary
Publikováno v:
In Bioorganic & Medicinal Chemistry 15 July 2024 109
Publikováno v:
In Journal of Molecular Structure 5 February 2024 1297 Part 2
Autor:
Panda, Arpita, Kobzev, Dmytro, Kulyk, Olesia, Bazylevich, Andrii, Gellerman, Gary, Patsenker, Leonid
Publikováno v:
In Dyes and Pigments November 2023 219
Autor:
Kobzev, Dmytro, Prasad, Chandrashekhar, Walunj, Dipak, Gotman, Hodaya, Semenova, Olga, Bazylevich, Andrii, Patsenker, Leonid, Gellerman, Gary
Publikováno v:
In European Journal of Medicinal Chemistry 5 April 2023 252
Autor:
Thankarajan, Ebaston, Tuchinsky, Helena, Aviel-Ronen, Sarit, Bazylevich, Andrii, Gellerman, Gary, Patsenker, Leonid
Publikováno v:
In Journal of Controlled Release March 2022 343:506-517
Autor:
Thankarajan, Ebaston, Walunj, Dipak, Bazylevich, Andrii, Prasad, Chandrashekhar, Hesin, Arkadi, Patsenker, Leonid, Gellerman, Gary
Publikováno v:
In Photodiagnosis and Photodynamic Therapy March 2022 37
Publikováno v:
In Journal of Photochemistry & Photobiology, A: Chemistry 1 March 2021 408
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olga Semenova, Dmytro Kobzev, Iryna Hovor, Melad Atrash, Faina Nakonechny, Olesia Kulyk, Andrii Bazylevich, Gary Gellerman, Leonid Patsenker
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 247 (2023)
Antibiotic resistance of pathogenic bacteria dictates the development of novel treatment modalities such as antimicrobial photodynamic therapy (APDT) utilizing organic dyes termed photosensitizers that exhibit a high cytotoxicity upon light irradiati
Externí odkaz:
https://doaj.org/article/4d5f54b02e02412fa923ef02446ea018
Autor:
Olga Furman, Alisa Zaporozhets, Dror Tobi, Andrii Bazylevich, Michael A. Firer, Leonid Patsenker, Gary Gellerman, Bat Chen R. Lubin
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1505 (2022)
The epidermal growth factor–epidermal growth factor receptor (EGF-EGFR) pathway has become the main focus of selective chemotherapeutic intervention. As a result, two classes of EGFR inhibitors have been clinically approved, namely monoclonal antib
Externí odkaz:
https://doaj.org/article/da8b9694f98443a2b2b3462694e6d015